课题基金 / 基金详情

DILTIAZEM ER DOSE RESPONSE IN PATIENTS WITH MILD TO MODERATE HYPERTENSION

DILTIAZEM ER DOSE RESPONSE IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
轻至中度高血压患者的地尔硫卓剂量反应
批准号：
3866401
负责人：
EDWARD C. CONRADI
金额：
$0.0万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3866401
关键词：
antihypertensive agents blood pressure cardiovascular disorder chemotherapy diltiazem dosage drug administration rate /duration drug adverse effect human subject human therapy evaluation hypertension placebos

项目摘要

项目成果

EDWARD C. CONRADI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to evaluate the blood pressure-lowering effect and safety of different doses of diltiazem-L-maleate, an investigational drug, newly prepared as a once-a-day or extended release tablet compared to placebo in patients with mild to moderate hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISRADIPINE, ENALAPRIL & ATENOLOL EFFECTS ON ELDERLY FEMALE PATIENTS
COMPARING EFFICACY AND TOLERABILITY OF FELODIPINE AND VERAPAMIL
ANTIHYPERTENSIVE EFFICACY AND SAFETY OF DIFFERENT DUP-753 (MK954) DOSES
COMPARING FELODPINE AND VERAPAMIL IN UNCOMPLICATED ESSENTIAL HYPERTENSION
海外基金